Published on 4 Nov 2024 on Investing.com
Earnings call: Kymera Therapeutics advances in immunology and oncology By...
Kymera Therapeutics, Inc. (NASDAQ: KYMR) held its Third Quarter 2024 Earnings Call on [date], where...
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free